News PRESS RELEASES Featured January 9, 2026 Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases January 9, 2026 Read more → January 9, 2026 IN THE NEWS Featured March 1, 2026 Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye March 1, 2026 Cell & Gene March 1, 2026 February 17, 2026 Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That. February 17, 2026 Forbes February 17, 2026 February 12, 2026 Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more February 12, 2026 Biotech TV February 12, 2026 January 21, 2026 JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing January 21, 2026 Inside Precision Medicine January 21, 2026 January 9, 2026 Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies January 9, 2026 BioPharma Dive January 9, 2026 January 9, 2026 Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines January 9, 2026 STAT January 9, 2026 January 9, 2026 Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments January 9, 2026 Wired January 9, 2026 January 9, 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies January 9, 2026 Endpoints News January 9, 2026
